Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 08/31/10
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 08/31/13
End: 12/31/14
Due: 12/31/15
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma | NCT01793298 | Asmacure Ltée | user2@example.com | None | 2013-03-31 | 2014-12-31 | 2015-12-31 | - | - | 2025-07-14 |
| Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma | NCT01190826 | Asmacure Ltée | user2@example.com | None | 2010-08-31 | 2012-02-29 | 2013-02-28 | - | - | 2025-07-14 |
| Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma | NCT01092403 | Asmacure Ltée | user2@example.com | None | 2010-04-30 | 2012-01-31 | 2013-01-31 | - | - | 2025-07-14 |
| Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD) | NCT01855230 | Asmacure Ltée | user2@example.com | None | 2013-08-31 | 2014-12-31 | 2015-12-31 | - | - | 2025-07-14 |